Log In
Print this Print this

Zenpep, pancrelipase (Enzepi) (EUR-1008) (formerly Zentase)

  Manage Alerts
Collapse Summary General Information
Company Allergan plc
DescriptionPorcine-derived pancreatic enzyme product (PEP)
Molecular Target Not available
Mechanism of ActionEnzyme replacement therapy
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentMarketed
Standard IndicationPancreatic insufficiency
Indication DetailsTreat exocrine pancreatic insufficiency (EPI); Treat exocrine pancreatic insufficiency (EPI) due to cystic fibrosis (CF) or other conditions such as chronic pancreatitis (CP), gastrointestinal surgery, and pancreatic cancer; Treat exocrine pancreatic insufficiency (EPI) in cystic fibrosis (CF) patients
Regulatory Designation
PartnerTakeda Pharmaceutical Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today